Fri, Jul 25, 2014, 2:59 AM EDT - U.S. Markets open in 6 hrs 31 mins

Recent

% | $
Click the to save as a favorite.

Exelixis, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • breezerwave breezerwave Nov 30, 2012 10:53 AM Flag

    Can Someone Explain ......

    Yes, the FDA approved. This provides high certainty the FDA will approve other indications, sales will grow, revenues will grow, patients will live longer, maybe eventually be cured and the stock price will go up and up.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "This provides high certainty the FDA will approve other indications, sales will grow, revenues will grow, patients will live longer, maybe eventually be cured and the stock price will go up and up."

      If those are your expectations you may be headed for more disappointment. MTC is a niche indication and the level of efficacy required for larger indications with more treatment options will be more difficult. "High certainty" is not in the cards. Be ready to settle for "likely" at best. Cabo is not a cure and it has not been demonstrated that it prolongs survival. My expectation is that it will prolong survival when dosed correctly, but we have to wait for the clinical data for confirmation of that expectation.

    • j.azevedo@sbcglobal.net j.azevedo Nov 30, 2012 11:51 AM Flag

      but not for a long time, in the meantime there are real stocks, like Apple

 
EXEL
4.21+0.43(+11.38%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.